Kentucky SB 191: AN ACT relating to opioid antagonists. Create a new section of KRS Chapter 218A to define "opioid antagonist" and require pharmacies to report to the CHFS and KASPER when prescriptions for opioid antagonists such as naloxone are filled; establish a penalty for noncompliance.

Status: To Health & Welfare (S) (as of 2017-02-15)

State: Kentucky · Session: 2017RS · Bill: SB 191

View Kentucky SB 191 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.